DARZALEX, Darzalex IV

What is this medication? DARZALEX, which contains the active ingredient daratumumab, is a prescription medication used to treat adults with multiple myeloma, a cancer of the plasma cells. It is classified as a monoclonal antibody that targets a specific protein called CD38 found on the surface of myeloma cells. By binding to these cells, the medication helps the immune system recognize and kill the cancer cells, while also directly inducing cell death and inhibiting the growth of the tumor.

This medication is administered by a healthcare professional as an intravenous infusion in a clinical setting. It can be used alone for patients who have already received several other treatments, or it may be used in combination with other chemotherapy or immunotherapy drugs for both newly diagnosed patients and those who have experienced a relapse. The dosage schedule usually involves frequent infusions at the beginning of treatment, which gradually become less frequent over several months.